Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Cochat

Showing results (41-50 of 225) with videos related to

Pageof 23
Sort By:
BMC Cancer|October 22, 2025
Therapeutic innovation in oncology: What do you mean? Whereof one cannot speak, thereof one must be silent, L. WittgensteinSylvie Chevret, Xavier Troussard, Charlotte Masia, et al.
American Journal of Medical Genetics. Part A|December 8, 2004
Maternal isodisomy of the telomeric end of chromosome 2 is responsible for a case of primary hyperoxaluria type 1Françoise Chevalier-Porst, Marie-Odile Rolland, Pierre Cochat, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 11, 2005
Long-term follow-up of metachronous marrow-kidney transplantation in severe type II sialidosis: what does success mean?Manuel Schiff, Irène Maire, Yves Bertrand, et al.
International Journal of Nephrology|July 13, 2011
Primary hyperoxaluriaJérôme Harambat, Sonia Fargue, Justine Bacchetta, et al.
Nephrologie & Therapeutique|April 29, 2021
[Interferent RNA treatment: Example of primary hyperoxaluria]Pierre Cochat, Anne-Laure Sellier-Leclerc, Aurélia Bertholet-Thomas, et al.
Pediatric Neurology|March 31, 2005
Fatal neurologic involvement in pediatric Wegener's granulomatosisTim Ulinski, Helene Martin, Brigitte Mac Gregor, et al.
Pediatric Nephrology (Berlin, Germany)|April 22, 2005
Triamcinolone acetonide: a new management of noncompliance in nephrotic childrenTim Ulinski, Anne Carlier-Legris, Déborah Schlecht, et al.
Kidney International|September 18, 2002
Better long-term functional adaptation to the child's size with pediatric compared to adult kidney donorsLaurence Dubourg, Pierre Cochat, Aoumeur Hadj-Aïssa, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 2, 2012
The consequences of chronic kidney disease on bone metabolism and growth in childrenJustine Bacchetta, Jérôme Harambat, Pierre Cochat, et al.
Nephrologie & Therapeutique|June 12, 2018
Cytomegalovirus infection in the first year after pediatric kidney transplantationCorentin Tanné, Pascal Roy, Émilie Frobert, et al.
Pageof 23

Showing results (41-50 of 225) with videos related to

Sort By:
Pageof 23
BMC Cancer|October 22, 2025
Therapeutic innovation in oncology: What do you mean? Whereof one cannot speak, thereof one must be silent, L. WittgensteinSylvie Chevret, Xavier Troussard, Charlotte Masia, et al.
American Journal of Medical Genetics. Part A|December 8, 2004
Maternal isodisomy of the telomeric end of chromosome 2 is responsible for a case of primary hyperoxaluria type 1Françoise Chevalier-Porst, Marie-Odile Rolland, Pierre Cochat, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 11, 2005
Long-term follow-up of metachronous marrow-kidney transplantation in severe type II sialidosis: what does success mean?Manuel Schiff, Irène Maire, Yves Bertrand, et al.
International Journal of Nephrology|July 13, 2011
Primary hyperoxaluriaJérôme Harambat, Sonia Fargue, Justine Bacchetta, et al.
Nephrologie & Therapeutique|April 29, 2021
[Interferent RNA treatment: Example of primary hyperoxaluria]Pierre Cochat, Anne-Laure Sellier-Leclerc, Aurélia Bertholet-Thomas, et al.
Pediatric Neurology|March 31, 2005
Fatal neurologic involvement in pediatric Wegener's granulomatosisTim Ulinski, Helene Martin, Brigitte Mac Gregor, et al.
Pediatric Nephrology (Berlin, Germany)|April 22, 2005
Triamcinolone acetonide: a new management of noncompliance in nephrotic childrenTim Ulinski, Anne Carlier-Legris, Déborah Schlecht, et al.
Kidney International|September 18, 2002
Better long-term functional adaptation to the child's size with pediatric compared to adult kidney donorsLaurence Dubourg, Pierre Cochat, Aoumeur Hadj-Aïssa, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 2, 2012
The consequences of chronic kidney disease on bone metabolism and growth in childrenJustine Bacchetta, Jérôme Harambat, Pierre Cochat, et al.
Nephrologie & Therapeutique|June 12, 2018
Cytomegalovirus infection in the first year after pediatric kidney transplantationCorentin Tanné, Pascal Roy, Émilie Frobert, et al.
Pageof 23